You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Assessing the public health impacts of legalizing recreational cannabis use in the USA
|
|---|---|
| Published in |
Clinical Pharmacology & Therapeutics, April 2015
|
| DOI | 10.1002/cpt.110 |
| Pubmed ID | |
| Authors |
W Hall, M Weier |
| Abstract |
A major challenge in assessing the public health impact of legalising cannabis use in Colorado and Washington State is the absence of any experience with legal cannabis markets. The Netherlands created a de facto legalised cannabis market for recreational use, but policy analysts disagree about how it has affected rates of cannabis use. Some US states have created de facto legal supply of cannabis for medical use. So far this policy does not appear to have increased cannabis use or cannabis-related harm. Given experience with more liberal alcohol policies, the legalisation of recreational cannabis use is likely to increase use among current users. It is also likely that legalisation will increase the number of new users among young adults but it remains uncertain how many may be recruited, within what time frame, among which groups within the population, and how many of these new users will become regular users. This article is protected by copyright. All rights reserved. |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 4 | 29% |
| United States | 2 | 14% |
| Australia | 2 | 14% |
| Portugal | 1 | 7% |
| Israel | 1 | 7% |
| Unknown | 4 | 29% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 86% |
| Scientists | 2 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 290 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Czechia | 1 | <1% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 285 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 49 | 17% |
| Student > Master | 47 | 16% |
| Student > Bachelor | 40 | 14% |
| Student > Ph. D. Student | 28 | 10% |
| Student > Doctoral Student | 18 | 6% |
| Other | 46 | 16% |
| Unknown | 62 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 49 | 17% |
| Psychology | 41 | 14% |
| Social Sciences | 34 | 12% |
| Agricultural and Biological Sciences | 19 | 7% |
| Neuroscience | 11 | 4% |
| Other | 46 | 16% |
| Unknown | 90 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 January 2020.
All research outputs
#1,617,542
of 24,577,646 outputs
Outputs from Clinical Pharmacology & Therapeutics
#239
of 4,386 outputs
Outputs of similar age
#20,624
of 269,692 outputs
Outputs of similar age from Clinical Pharmacology & Therapeutics
#5
of 26 outputs
Altmetric has tracked 24,577,646 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,386 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,692 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.